VENUS REMEDIES
Intrinsic Value | Fundamental Analysis

BOM : 526953     NSE : VENUSREM    
LT :  
    Long Term Analysis
Fundamentals : Bad
Valuation : Bad [Stock is Expensive]
Debt : High
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : None or < 25%
May 19,2022
Price(EOD): β‚Ή 240.90
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: β‚Ή 322.81 Cr
Value of β‚Ή 1 Lac invested in VENUS REMEDIES
on May 19,2017 (price: β‚Ή 100.75)

β‚Ή 1 L

β‚Ή 2.39 L

1W : 6.6% 1M : -23.7% 1Y : -17.4%
COMMUNITY POLL
for VENUS REMEDIES
Please provide your vote to see the results
Industry Peers & Returns1W1M1Y
VENUS REMEDIES 6.6% -23.7% -17.4%
SUN PHARMACEUTICAL INDUSTRIES 0.3% -3.9% 30.9%
DIVIS LABORATORIES -1.9% -4.6% 7.5%
DR REDDYS LABORATORIES 0.1% -6.7% -26.3%
CIPLA 0.6% -6.1% 8.7%
GLAND PHARMA 3.4% -3.2% 11.2%
PIRAMAL ENTERPRISES 4.5% -14.9% 19.9%
CADILA HEALTHCARE -0.6% -5% -43.2%
TORRENT PHARMACEUTICALS 0.4% -8.8% -4.5%

FUNDAMENTAL ANALYSIS OF VENUS REMEDIES

 
Fundamentals Score
[ Q(TTM): Dec2021, Y: Mar2021
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]


VALUATION OF VENUS REMEDIES

 
Valuation Score
[As on : May 19,2022 ]

Ratio Consolidated
P/E
P/B
P/S
4.81
P/E Calculated based on EPS of 50.04
[ Mar2021 - Consolidated Results ]

0.77
P/B Calculated based on Book Value of 313.18
[ Mar2021 - Consolidated Results ]

0.57
P/S Calculated based on Revenues of 568.086 Cr
[ TTM - Consolidated Results ]

Financial Ratios →

Insights πŸ’‘ There are potential 21% undervalued companies ! Discover More →

FAIR VALUE OF VENUS REMEDIES

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
NA
17%
23%

Insights πŸ’‘ You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF VENUS REMEDIES


Insights πŸ’‘ There are 5% companies with bullish price momentum currently! Discover More →

VENUS REMEDIES vs SENSEX


Insights πŸ’‘ You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF VENUS REMEDIES

Year Debt/Equity ratio
Standalone Consolidated
2021
2020
2019
Avg_3yrs
0.12
0.65
0.86
0.54
0.13
0.68
0.9
0.57
[Last Annual Data : Mar2021]
Financial Ratios →

PLEDGED PROMOTER SHARES OF VENUS REMEDIES

Pledged Promoter Shares
0 %
As on : Mar2022

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF VENUS REMEDIES

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
-38.61%
-54.45%
-78.11%
-75.61%
1.97%
-31.22%
-66.12%
-51.57%
QtrlyTrend
-6
Latest Qtr: Dec2021
Quarterly Result Analysis →


VENUS REMEDIES related INDICES

BSE Indices1W1M1Y
S&P BSE SMALL CAP 3.2% -11.7% 16.2%
S&P BSE MIDSMALLCAP 2.7% -11.3% 12.2%
S&P BSE HEALTHCARE 1.2% -9.9% -7.6%
S&P BSE ALLCAP 0.8% -9.3% 9.3%
No NSE index found

You may also like the below Video Courses


FAQ about VENUS REMEDIES


Is VENUS REMEDIES good for long term investment?

As on May 19,2022, the Fundamentals of VENUS REMEDIES look Poor and hence it may not be good for long term investment ! See Financial Performance of VENUS REMEDIES . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is VENUS REMEDIES UnderValued or OverValued?

As on May 19,2022, VENUS REMEDIES is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of VENUS REMEDIES ?

As on May 19,2022, the Intrinsic Value of VENUS REMEDIES is Rs. 200.51 determined based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. -51.39
Fair Value [Median EV / Sales Model] : Rs. 205.53
Fair Value [Median Price / Sales Model] : Rs. 195.49
Median Fair Value of VENUS REMEDIES : Rs. 200.51

Is VENUS REMEDIES trading at a Premium or Discount?

As on May 19,2022, VENUS REMEDIES is trading at a Premium of 20% based on the estimates of Median Intrinsic Value!

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].


All Stocks : A - Z
ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z